Patients:

Huntington's Disease

We are continuously advancing our broad pipeline of innovative gene therapies to bring new treatments to patients with severe genetic diseases.

Huntington's Disease

Huntington’s disease is a severe genetic neurodegenerative disorder causing loss of muscle coordination, behavioral abnormalities and cognitive decline, resulting in complete physical and mental deterioration over a 12-15 year period of time. The disease is caused by an autosomal dominant mutation, a cytosine-adenine-guanine (CAG) expansion, in the first exon of the Huntingtin gene leading to a non-functional, aggregation prone mutated protein. Despite the clear etiology, there are no therapies available to treat the disease, delay onset or slow progression of a patient’s decline.

 

> Contact us for more information
> Gene therapy information (PDF)